Skip to main content
ConductScienceScienceDex

Zhou, Pengbo

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #14,715
Unclaimed recordClaim profile
  • Rising Star
  • R01 Holder
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award categories

  • Pathology

NIH Funding · FY2022

Linked Award Amount
$728.7K
Full award amounts, FY2022
Award Records
2
Records listing this PI
Award-Linked Rank
#14,715
By linked amount among FY2022 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Zhou, Pengbo. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2022 award records by amount

NIH award records listing Zhou, Pengbo as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA221152-05R01Contact PI
    G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis
    Weill Cornell Medicine · Pathology (NIH department code)
    $482.5K
    award amount
  • 3R41CA265583-01S1R41Contact PI
    Small Molecule CUL4 Inhibitors as Dual Precision Oncology and Immuno-Oncology Drugs
    Culnexin Therapeutics, Inc.
    $246.1K
    award amount

Award organizations

Organizations that administered FY2022 awards listing Zhou, Pengbo as a PI.

Weill Cornell Medicine
NY
$482.5K
1 grant
Culnexin Therapeutics, Inc.
$246.1K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Weill Cornell Medicine
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #9177
  4. 2007
    $1M Cumulative Funding
  5. 2007
    Multi-Institutional Research
    Awards at 2 institutions
  6. 2009
    $2M Cumulative Funding
  7. 2010
    R01 Grant Holder
  8. 2018
    $5M Cumulative Funding
  9. 2020
    Entered Top 25% Nationally
    Ranked #2808

Explore further

Find collaborators for Zhou, Pengbo

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →